Optipharm.CO.,LTD (KOSDAQ:153710)
South Korea · Delayed Price · Currency is KRW 4,755.00
-10.00 (-0.21%)
At close: May 29, 2026
Optipharm.CO.,LTD Cash Flow Statement
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Income | -2,115 | -2,499 | -2,357 | -2,437 | -2,045 | -3,080 |
Depreciation & Amortization | 1,679 | 1,674 | 1,614 | 1,433 | 1,120 | 1,076 |
Loss (Gain) From Sale of Assets | 15.93 | 16.24 | -0.97 | -1.06 | -3.05 | 1.76 |
Loss (Gain) From Sale of Investments | -132.68 | -175.23 | -185.27 | -184.65 | -346.47 | -90.2 |
Loss (Gain) on Equity Investments | - | - | - | 1.49 | 0.35 | 0.29 |
Stock-Based Compensation | 646.07 | 704.8 | 587.33 | - | -33.61 | -5.9 |
Provision & Write-off of Bad Debts | -1.04 | -0.78 | 3.35 | -0.2 | -0.33 | 1.29 |
Other Operating Activities | 438.58 | 673.56 | 480.51 | 362.29 | 298.11 | -1,063 |
Change in Accounts Receivable | 1,885 | -504.72 | 288.1 | 476.25 | -899.4 | -95.74 |
Change in Inventory | -423.49 | -504.55 | -28.1 | -261.97 | -42.84 | -339.3 |
Change in Accounts Payable | 29.3 | 24.48 | -89.16 | 152.63 | -631.57 | 226.52 |
Change in Other Net Operating Assets | -2,729 | -963.45 | -908.9 | -1,264 | 187.12 | 1,399 |
Operating Cash Flow | -707.18 | -1,555 | -595.5 | -1,723 | -2,396 | -1,969 |
Capital Expenditures | -1,182 | -2,507 | -1,677 | -1,672 | -4,572 | -725.18 |
Sale of Property, Plant & Equipment | 1.4 | 1.4 | 29.96 | 1.7 | 5.93 | 11.81 |
Sale (Purchase) of Intangibles | -39.9 | -38.05 | -58.71 | -65.25 | -32.27 | -32.26 |
Investment in Securities | 3,151 | 3,226 | 2,409 | -1,854 | 2,621 | -6,789 |
Other Investing Activities | 192.71 | 131.02 | 317.03 | - | - | 147.56 |
Investing Cash Flow | 2,123 | 813.61 | 1,020 | -3,589 | -1,978 | -7,387 |
Short-Term Debt Issued | - | 10,310 | 13,700 | 7,700 | 5,200 | 5,100 |
Total Debt Issued | 10,310 | 10,310 | 13,700 | 7,700 | 5,200 | 5,100 |
Short-Term Debt Repaid | - | -10,750 | -12,560 | -5,560 | -3,560 | -3,560 |
Long-Term Debt Repaid | - | -163.73 | -197.01 | -147.29 | -130.41 | -156.45 |
Total Debt Repaid | -10,976 | -10,914 | -12,757 | -5,707 | -3,690 | -3,716 |
Net Debt Issued (Repaid) | -665.66 | -603.73 | 942.99 | 1,993 | 1,510 | 1,384 |
Issuance of Common Stock | - | - | - | - | 250.5 | 435 |
Other Financing Activities | - | - | -0 | -0 | -0 | -0 |
Financing Cash Flow | -665.66 | -603.73 | 942.99 | 1,993 | 1,760 | 1,819 |
Miscellaneous Cash Flow Adjustments | - | - | -0 | -0 | - | - |
Net Cash Flow | 750.31 | -1,345 | 1,367 | -3,319 | -2,613 | -7,538 |
Free Cash Flow | -1,889 | -4,062 | -2,273 | -3,395 | -6,968 | -2,695 |
Free Cash Flow Margin | -8.29% | -18.18% | -11.58% | -19.54% | -43.53% | -18.90% |
Free Cash Flow Per Share | -128.37 | -276.86 | -155.29 | -231.26 | -477.10 | -185.50 |
Cash Interest Paid | 460.55 | 382.85 | 516.81 | 463.38 | 319.85 | 158.37 |
Cash Income Tax Paid | - | -25.71 | -14.89 | 36.58 | 36.09 | -31.66 |
Levered Free Cash Flow | -468.97 | -2,578 | -1,010 | -2,006 | -6,486 | -2,171 |
Unlevered Free Cash Flow | -159.61 | -2,263 | -669.33 | -1,708 | -6,265 | -2,062 |
Change in Working Capital | -1,238 | -1,948 | -738.06 | -897.07 | -1,387 | 1,190 |